Feasibility of a Hybrid Risk-Adapted Monitoring System in Investigator-Sponsored Trials in Cancer
- Publisher
- THERAPEUTIC INNOVATION & REGULATORY SCIENCE
- Language
- 영어
- ISSN
- 2168-4790
- Citation Volume
- 55
- Citation Number
- 1
- Citation Start Page
- 180
- Citation End Page
- 189
-
Appears in Collections:
- Medicine > Medicine
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.